Cypress Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-370
Closed -$54.1K 222
2024
Q2
$54.1K Buy
+370
New +$55K 0.01% 111
2023
Q3
Sell
-13,230
Closed -$2.19M 87
2023
Q2
$2.19M Buy
13,230
+289
+2% +$46.6K 0.63% 32
2023
Q1
$2.01M Sell
12,941
-626
-5% -$101K 0.63% 30
2022
Q4
$2.4M Buy
13,567
+164
+1% +$28.3K 0.75% 20
2022
Q3
$2.19M Buy
13,403
+1,872
+16% +$317K 0.77% 20
2022
Q2
$2.05M Buy
11,531
+514
+5% +$91.6K 0.29% 59
2022
Q1
$1.95M Sell
11,017
-1,390
-11% -$237K 0.24% 72
2021
Q4
$2.12M Buy
12,407
+1,936
+18% +$317K 0.24% 69
2021
Q3
$1.69M Buy
10,471
+1,246
+14% +$213K 0.21% 74
2021
Q2
$1.52M Buy
9,225
+1,285
+16% +$213K 1.49% 29
2021
Q1
$1.3M Buy
7,940
+568
+8% +$91.9K 0.53% 39
2020
Q4
$1.16M Sell
7,372
-17
-0.2% -$2.51K 0.53% 37
2020
Q3
$1.09M Buy
7,389
+67
+0.9% +$9.91K 0.51% 41
2020
Q2
$1.03M Buy
+7,322
New +$1.07M 0.46% 44
2019
Q4
$855K Buy
5,860
+329
+6% +$44.6K 0.36% 47
2019
Q3
$716K Buy
5,531
+421
+8% +$55.5K 0.33% 52
2019
Q2
$712K Buy
5,110
+226
+5% +$31.3K 0.32% 47
2019
Q1
$683K Buy
4,884
+470
+11% +$63K 0.28% 46
2018
Q4
$570K Buy
+4,414
New +$616K 0.26% 46

Other funds holding JNJ

Cypress Capital's JNJ Position: Q3 2024 in Review

Cypress Capital sold out of Johnson & Johnson (JNJ) in Q3 2024, closing a stake of 370 shares — an estimated $54.1K sold.

Cypress Capital first reported a position in JNJ in Q4 2018 and held it in 19 quarters. The position peaked at $2.4M in Q4 2022. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Cypress Capital reported no remaining Johnson & Johnson position as of Q3 2024 after selling out during the quarter.
  • Cypress Capital sold 370 Johnson & Johnson shares in Q3 2024, an estimated $54.1K.
  • Cypress Capital first reported a position in Johnson & Johnson in Q4 2018 and held it in 19 quarters.
  • Cypress Capital's Johnson & Johnson position peaked at $2.4M in Q4 2022.
  • 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Cypress Capital's 13F filing for Q3 2024, filed 12 Nov 2024.